for an upfront payment of $45m big pharma can save themselves not only the cost of developing the drug ($45m to date), but also the 7 years of development @rlj
The MD has said that its time to realise the value of the investment in AD-214. So, what is the value of that investment to date? For a biotech located in the US, one might conservatively imagine that getting a drug candidate in readiness for Phase 2 would be north of US$100m. According to the balance sheet for AdAlta as at 31 Dec 2023, it appears that the figure - as represented by accumulated losses - is AUD$45m.
By chance, IPF assets - according to the Gems presentation - command upfront license payments of more than US$45m. Neat numerical symmetry. Lets call the currency difference between USD and AUD as the initial return on investment, following the recoupment of investment to date.
I know its just playing with numbers but its kind of funny how the answer between the company balance sheet and the corporate presentation is 45. Its close enough to another well known number so lets call it the Hitchhikers Guide to Investment Return.
- Forums
- ASX - By Stock
- 1AD
- Ann: Positive AD-214 Phase I extension study results
Ann: Positive AD-214 Phase I extension study results, page-170
-
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $11.51M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $6.701K | 352.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1058823 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1058823 | 0.017 |
7 | 968104 | 0.016 |
4 | 1659994 | 0.015 |
1 | 75000 | 0.014 |
1 | 50000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 250000 | 1 |
0.021 | 372500 | 2 |
0.022 | 500000 | 1 |
0.023 | 17643 | 1 |
0.024 | 220050 | 2 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online